Low-Dose Endotoxemia and the Acute Phase Response

Herlev Hospital

Status: Unknown

Conditions: Endotoxemia; Sepsis

Treatments: Drug: E. Coli endotoxin

Study type: Interventional

Funder types: Other

Identifiers

NCT00197899

KA 04015

Details and patient eligibility

About

The purpuse of this study is to examine the acute phase respons when different doses of E. Coli Endotoxin is injected in healty volunters.

Sex: Male

Ages: 18 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Healty volunteers -

Exclusion Criteria:

Infection 14 days prior to the trial Regular medication Present and /or former heart disease -

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind